To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives (DOC)
Adherence to the dosing scheme is the principal element of Combined Oral Contraceptives efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Prospective, Open-label Observational Survey Evaluating Patients Compliance to Administration Regimen During Low Dose Combined Oral Contraceptive Use in Everyday Praxis Data on Oral Contraceptives Compliance - DOC Study|
- The percentage of users showing noncompliant behaviors [ Time Frame: 3 consecutive cycles ] [ Designated as safety issue: No ]
- The characteristics of noncompliant behavior [ Time Frame: 3 consecutive cycles ] [ Designated as safety issue: No ]
- The relation between noncompliant behavior and selected factors [ Time Frame: 3 consecutive cycles ] [ Designated as safety issue: No ]
|Study Start Date:||December 2007|
|Study Completion Date:||May 2008|
|Primary Completion Date:||May 2008 (Final data collection date for primary outcome measure)|
Drug: EE/DRSP (Yasmin Product Family)
One tablet per day, orally, 21 tablets followed by 7 days, during three consecutive cycles.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01198444
|Many Locations, Poland|
|Study Director:||Bayer Study Director||Bayer|